Literature DB >> 19041435

Cost effectiveness of contraceptives in the United States.

James Trussell1, Anjana M Lalla, Quan V Doan, Eileen Reyes, Lionel Pinto, Joseph Gricar.   

Abstract

BACKGROUND: The study was conducted to estimate the relative cost effectiveness of contraceptives in the United States from a payer's perspective.
METHODS: A Markov model was constructed to simulate costs for 16 contraceptive methods and no method over a 5-year period. Failure rates, adverse event rates and resource utilization were derived from the literature. Sensitivity analyses were performed on costs and failure rates.
RESULTS: Any contraceptive method is superior to "no method". The three least expensive methods were the copper-T intrauterine device (IUD) (US$647), vasectomy (US$713) and levonorgestrel (LNG)-20 intrauterine system (IUS) (US$930). Results were sensitive to the cost of contraceptive methods, the cost of an unintended pregnancy and plan disenrollment rates.
CONCLUSION: The copper-T IUD, vasectomy and the LNG-20 IUS are the most cost-effective contraceptive methods available in the United States. Differences in method costs, the cost of an unintended pregnancy and time horizon are influential factors that determine the overall value of a contraceptive method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041435      PMCID: PMC3638200          DOI: 10.1016/j.contraception.2008.08.003

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  33 in total

1.  Economic analysis of long-term reversible contraceptives. Focus on Implanon.

Authors:  C J Phillips
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.

Authors:  Lawrence B Finer; Stanley K Henshaw
Journal:  Perspect Sex Reprod Health       Date:  2006-06

3.  The cost of unintended pregnancy in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2007-01-18       Impact factor: 3.375

4.  Overstating the cost savings from contraceptive use.

Authors:  James Trussell
Journal:  Eur J Contracept Reprod Health Care       Date:  2008-09       Impact factor: 1.848

5.  The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.

Authors:  I Mavranezouli
Journal:  Hum Reprod       Date:  2008-03-26       Impact factor: 6.918

6.  Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users.

Authors:  T Backman; S Huhtala; T Blom; R Luoto; I Rauramo; M Koskenvuo
Journal:  BJOG       Date:  2000-03       Impact factor: 6.531

7.  Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.

Authors:  Fernando Augusto Barreiros; Cristina Aparecida Falbo Guazzelli; Fábio Fernando de Araújo; Ricardo Barbosa
Journal:  Contraception       Date:  2007-01-18       Impact factor: 3.375

8.  Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth.

Authors:  Anjani Chandra; Gladys M Martinez; William D Mosher; Joyce C Abma; Jo Jones
Journal:  Vital Health Stat 23       Date:  2005-12

9.  Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.

Authors:  Barbara Vaughan; James Trussell; Kathryn Kost; Susheela Singh; Rachel Jones
Journal:  Contraception       Date:  2008-07-24       Impact factor: 3.375

10.  Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

Authors:  Susan S Jick; James A Kaye; Stefan Russmann; Hershel Jick
Journal:  Contraception       Date:  2006-01-26       Impact factor: 3.375

View more
  71 in total

1.  The impact of out-of-pocket expense on IUD utilization among women with private insurance.

Authors:  Aileen M Gariepy; Erica J Simon; Divya A Patel; Mitchell D Creinin; Eleanor B Schwarz
Journal:  Contraception       Date:  2011-08-17       Impact factor: 3.375

2.  Associations between recent contraceptive use and quality of life among women.

Authors:  Sanithia L Williams; Sara M Parisi; Rachel Hess; E Bimla Schwarz
Journal:  Contraception       Date:  2011-09-19       Impact factor: 3.375

3.  The Use of ACOG Guidelines: Perceived Contraindications to IUD and Implant Use Among Family Planning Providers.

Authors:  Ash E Philliber; Heather Hirsch; Claire D Brindis; Rita Turner; Susan Philliber
Journal:  Matern Child Health J       Date:  2017-09

4.  Development and Uptake of Long-Acting Reversible Contraception Services in Rwanda, 2009-2016.

Authors:  Rosine Ingabire; Jeannine Mukamuyango; Julien Nyombayire; Sarah Rae Easter; Rachel Parker; Amelia Mazzei; Robertine Sinabamenye; Amanda Tichacek; Susan Allen; Etienne Karita; Kristin M Wall
Journal:  J Womens Health (Larchmt)       Date:  2019-07-05       Impact factor: 2.681

5.  Clinical versus laboratory screening for sexually transmitted infections prior to insertion of intrauterine contraception among women living with HIV/AIDS: a randomized controlled trial.

Authors:  Othman Kakaire; Josaphat Kayogoza Byamugisha; Nazarius Mbona Tumwesigye; Kristina Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2015-05-15       Impact factor: 6.918

6.  Training at a faith-based institution matters for obstetrics and gynecology residents: results from a regional survey.

Authors:  Maryam Guiahi; Carolyn L Westhoff; Sondra Summers; Kimberly Kenton
Journal:  J Grad Med Educ       Date:  2013-06

Review 7.  Vasectomy occlusion techniques for male sterilization.

Authors:  Lynley A Cook; Huib A A M Van Vliet; Laureen M Lopez; Asha Pun; Maria F Gallo
Journal:  Cochrane Database Syst Rev       Date:  2014-03-30

8.  Extending contraceptive coverage under the Affordable Care Act saves public funds.

Authors:  Suzanne Burlone; Alison B Edelman; Aaron B Caughey; James Trussell; Stella Dantas; Maria I Rodriguez
Journal:  Contraception       Date:  2012-07-25       Impact factor: 3.375

Review 9.  Contraception for cancer survivors.

Authors:  Eleanor Bimla Schwarz; Rachel Hess; James Trussell
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

10.  Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception.

Authors:  James Trussell; Fareen Hassan; Nathaniel Henry; Jennifer Pocoski; Amy Law; Anna Filonenko
Journal:  Contraception       Date:  2014-01-24       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.